"We are MercyOne: a connected system of health care facilities and services dedicated to helping you live your best life."

During the past decade, Covenant Cancer Treatment Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 26 clinical trials were completed, i.e. on average, 371.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 12 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covenant Cancer Treatment Center" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covenant Cancer Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Covenant Cancer Treatment Center" are "Breast Cancer" (7 trials), "Breast Adenocarcinoma" (3 trials), "Colorectal Cancer" (3 trials), "Lung Cancer" (3 trials) and "Prostate Cancer" (3 trials). Many other conditions were trialed in "Covenant Cancer Treatment Center" in a lesser frequency.

Most popular intervention types in "Covenant Cancer Treatment Center" are "Drug" (35 trials), "Other" (22 trials), "Biological" (16 trials), "Radiation" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (13 trials), "Quality-of-Life Assessment" (8 trials), "Cyclophosphamide" (5 trials), "placebo" (5 trials) and "Doxorubicin Hydrochloride" (4 trials). Other intervention names were less common.

The vast majority of trials in "Covenant Cancer Treatment Center" are 27 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Covenant Cancer Treatment Center". undefined are not yet recruiting, 1 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Covenant Cancer Treatment Center, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Covenant Cancer Treatment Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".